ArticleNeuro-oncology2022

Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin-a novel tumor checkpoint controller targeting microtubules.

Danielle M Burgenske et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.